Next 10 |
home / stock / syk / syk articles
Boston Scientific Corporation (NYSE: BSX) has been struggling due to unfavorable currency movement and macroeconomic woes. Strong competitors in th...
Globus Medical (NYSE: GMED) continues to gain from surging demand for its Musculoskeletal Solutions products. Meanwhile, the company is expanding i...
In the current session, the stock is trading at $351.79, after a 0.63% spike. Over the past month, Stryker Inc. (NYSE:SYK) stock increased by 1.24%...
In a recent report, global wealth manager UBS identified the sectors likely to drive the next wave of technological innovation and the stocks that ...
Stryker (NYSE:SYK) has outperformed the market over the past 20 years by 2.97% on an annualized basis producing an average annual return of 11.01%....
On March 11, it was revealed in an SEC filing that William E. Berry, Jr., VP at Stryker (NYSE:SYK) executed a significant exercise of company stock...
Stryker (NYSE:SYK) has outperformed the market over the past 15 years by 1.96% on an annualized basis producing an average annual return of 15.02%....
Disclosed on February 7, Ronda E Stryker, Board Member at Stryker (NYSE:SYK), executed a substantial insider sell as per the latest SEC filing. Wha...
A significant insider transaction involving the exercise of company stock options was reported on February 7, by Yin C Becker, VP at Stryker (NYSE:...
News, Short Squeeze, Breakout and More Instantly...
2024-04-15 09:00:04 ET Ryan Zimmerman from BTIG issued a price target of $366.00 for SYK on 2024-04-15 07:36:00. The adjusted price target was set to $366.00. At the time of the announcement, SYK was trading at $342.05. The overall price target consensus is at $279.52 wi...
Boston Scientific Corporation (NYSE: BSX) has been struggling due to unfavorable currency movement and macroeconomic woes. Strong competitors in th...